awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q57110523-53A2C033-A5DE-4BB4-9DBC-DDAF96F14E56
Q57110523-53A2C033-A5DE-4BB4-9DBC-DDAF96F14E56
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57110523-53A2C033-A5DE-4BB4-9DBC-DDAF96F14E56
NGM282 for Treatment of Patients With Primary Biliary Cholangitis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial
P2860
Q57110523-53A2C033-A5DE-4BB4-9DBC-DDAF96F14E56
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57110523-53A2C033-A5DE-4BB4-9DBC-DDAF96F14E56
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
0f644155e7ccc72e5490822e0d4f3f5cb813f364
P2860
Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study.